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Background: Neuregulin1 (NRG1) influences the development of white matter connectivity and is implicated in genetic susceptibility to
schizophrenia. The cingulum bundle is a white matter structure implicated in schizophrenia. Its anterior component is especially impli-
cated, as it provides reciprocal connections between brain regions with prominent involvement in the disorder. Abnormalities in the struc-
tural integrity of the anterior cingulum in patients with schizophrenia have been reported previously. The present study investigated the
potential contribution of NRG1 variation to anterior cingulum abnormalities in participants with schizophrenia. Methods: We studied
31 men with schizophrenia and 36 healthy men using diffusion tensor imaging to investigate the association between fractional
anisotropy in the anterior cingulum and a single-nucleotide polymorphism (SNP8NRG221533: rs35753505) of NRG1. Results: Consist-
ent with previous reports, fractional anisotropy was significantly reduced in the anterior cingulum in the schizophrenia group. Moreover,
the results revealed a significant group (schizophrenia, control) by genotype (C/C, T carriers, including CT and TT) interaction between
genetic variation in NRG1 and diagnosis of schizophrenia, such that the patients with the T allele for SNP8NRG221533 had significantly
decreased anterior cingulum fractional anisotropy compared with patients homozygous for the C allele and healthy controls who were
T carriers. Limitations: Limitations of our study included the small sample size of the TT subgroup and our use of only fractional
anisotropy as an index of myelin integrity. In addition, the use of diffusion tensor imaging acquisition methods limited our ability to study
other brain regions that may be involved in schizophrenia. Conclusion: Our results suggest that NRG1 variation may play a role in the
pathophysiology of anterior cingulum abnormalities in patients with schizophrenia.
Contexte : La neuroréguline-1 (NRG1) influe sur le développement de la connectivité de la substance blanche et participe à la prédispo-
sition génétique à la schizophrénie. Le faisceau cingulaire est une structure de la substance blanche qui intervient dans la schizo-
phrénie. Sa partie antérieure est particulièrement en cause, puisqu’elle assure les connexions réciproques entre les principales régions
du cerveau qui jouent un rôle dans la maladie. Des rapports ont déjà fait mention d’anomalies de l’intégrité structurale du cingulum
antérieur chez des patients schizophrènes. La présente étude a analysé la contribution potentielle des fluctuations de NRG1 dans les
anomalies affectant le cingulum antérieur chez les participants atteints de schizophrénie. Méthodes : Nous avons étudié 31 hommes
atteints de schizophrénie et 36 hommes en bonne santé au moyen de techniques d’imagerie par tenseur de diffusion afin d’explorer le
lien entre l’anisotropie fractionnelle au niveau du cingulum antérieur et un polymorphisme de nucléotides simples (PNS8NRG221533:
rs35753505) de la NRG1. Résultats : Conformément à des rapports antérieurs, l’anisotropie fractionnelle s’est révélée significativement
moindre dans le cingulum antérieur du groupe atteint de schizophrénie. De plus, les résultats ont révélé une interaction significative
selon le groupe (schizophrènes c. témoins) en fonction du génotype (porteurs des allèles C/C et T, y compris CT et TT) entre la variation
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Introduction
Convergent findings implicate genes involved in white mat-
ter development in the pathophysiology of schizophrenia.1–5
Neuregulin 1 (NRG1) has recently been shown to play a role
in the development of white matter, as well as in susceptibil-
ity to schizophrenia.6 Increasing evidence suggests that
NRG1 affects the regulation of central nervous system (CNS)
myelination by inducing the migration and differentiation of
oligodendrocytes in the CNS.7,8 Moreover, preclinical evi-
dence demonstrates that alterations in NRG1–ErbB signalling
lead to abnormalities in oligodendrocyte structure and func-
tion, such as reduced myelin thickness and slower conduc-
tion velocity in CNS axons. These changes can cause alter-
ations in dopaminergic function and behaviour relevant to
neuropsychiatric disorders.9 In patients with schizophrenia,
altered levels of NRG1 type III (SMDF), which is related to
myelination, have been found in peripheral leukocytes.10
More recently, the NRG1α isoform was demonstrated to be
significantly reduced in white matter of the prefrontal cortex
in patients with schizophrenia.11 Magnetic resonance imaging
studies provide further evidence of the association between
NRG1 and the structural integrity of medial frontal white
matter in healthy individuals.12,13 These data suggest that
NRG1 contributes to the pathophysiology of schizophrenia
by exerting an effect on white matter.
Replications of the linkage between the NRG1 gene and
schizophrenia in several populations implicate NRG1 as a
candidate gene for schizophrenia.14–23 Since the deCODE
haplotype was linked to schizophrenia by a deCODE
group,15 the single-nucleotide polymorphism (SNP;
SNP8NRG221533: rs35753505) from the deCODE haplotype
has been reported to be associated with schizophrenia in
diverse populations,15,16,21–23 including the northern Chinese
Han population.16 Neuregulin 1 does present population dif-
ferences in allele and haplotype frequencies.24 Studies of East
Asian (mainly Chinese, Japanese and Korean) populations
have been inconsistent in finding associations between
schizophrenia and SNP8NRG221533 and other polymor-
phisms.16,19,20,25–27 Even within the Chinese population, the re-
sults were diverse.16,25–27 In the present study, we examined
SNP8NRG221533 as it is associated with schizophrenia,
specifically in the northern Chinese Han population from
which our sample was drawn.16 This SNP has also been
associated with the structural integrity of medial frontal
white matter in healthy individuals.12
Diffusion tensor imaging (DTI) provides the opportunity
to study white matter architecture. One of the measurements
used in DTI is fractional anisotropy, which provides a meas-
ure of the organization and coherence of white matter
tracts.28,29 Decreases in fractional anisotropy have been de-
tected in disorders of CNS myelination,30–32 suggesting that
fractional anisotropy is a measure sensitive to myelination
abnormalities. Convergent evidence has implicated dys-
myelination in schizophrenia,5 and the cingulum bundle is
especially implicated as a structure with white matter pathol-
ogy in schizophrenia. The white matter of the anterior com-
ponent of the cingulum bundle is particularly implicated in
schizophrenia as it provides reciprocal connections between
brain regions with prominent involvement in the disorder,33
including regions that myelinate late and are implicated in
the emergence of the disorder in late adolescence/young
adulthood such as the dorsolateral prefrontal, the anterior
cingulate and the temporal cortices. Indeed, abnormality in
structural integrity of the anterior cingulum is a relatively
well-replicated finding among patients with schizophrenia in
DTI studies.34–38 In our first DTI study of patients with schizo-
phrenia,34 we investigated multiple white matter regions and
the only region that demonstrated a significant difference in
schizophrenia was the anterior cingulum bundle. In a sub-
sequent study,35 we optimized acquisition for study of the
cingulum and again found decreased fractional anisotropy
values in patients with schizophrenia that were localized in
the anterior cingulum region.
In the present study, we used DTI to test the hypothesis
that variation in SNP8NRG221533 influences the struc-




We recruited 2 relatively homogeneous groups of men of
northern Chinese descent (Han): patients with schizophrenia
(International Classification of Diseases, version 10, criteria
established by the consensus of clinical and structured clinical
interview) and healthy controls. Participants provided written
informed consent after complete description of the study in
accordance with the protocol approved by the Medical Ethics
Committee of Peking University.
Diffusion tensor imaging acquisition and processing
We acquired diffusion tensor images according to methods
described previously.35 Briefly, we obtained all scans using a
génétique de la NRG1 et le diagnostic de schizophrénie, de sorte que les patients porteurs de l’allèle T pour le PNS8NRG221533
présentaient une anisotropie fractionnelle significativement diminuée au niveau du cingulum antérieur, comparativement aux patients
homozygotes pour l’allèle C et aux témoins en bonne santé porteurs de l’allèle T. Limites : Les limites de notre étude comprennent la
petite taille de l’échantillon du sous-groupe TT et l’utilisation de l’anisotropie fractionnelle comme seul indice de l’intégrité de la myéline.
De plus, l’utilisation de méthodes d’acquisition d’image par tenseur de diffusion a limité notre capacité d’analyser d’autres régions
cérébrales potentiellement en cause dans la schizophrénie. Conclusion : Selon nos résultats, les fluctuations de NRG1 pourraient jouer
un rôle dans la physiopathologie des anomalies du cingulum antérieur observées chez les patients schizophrènes.
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1.5 T magnetic resonance scanner (GE Medical Systems)
equipped with shielded magnetic field gradients of up to
40 mT/m. We acquired diffusion-weighted images with a
single-shot echo-planar imaging sequence in alignment with
the anterior commissure–posterior commissure plane. We
applied the diffusion sensitizing gradients along 25 non-
collinear directions with a b value of 1000 s/mm2 together
with an acquisition without diffusion weighting. The acquisi-
tion parameters were repetition time (TR) = 4000 ms, echo
time (TE) = 80 ms, matrix = 128 × 128, field of view
(FOV) = 24 × 24 cm2, number of excitations = 3, slice thick-
ness = 3 mm without gap. We also obtained T1-weighted
sagittal magnetic resonance images (3-dimensional [3-D]
spoiled gradient recalled acquisition) for anatomic localization
(TR = 8.5 ms, TE = 3.2 ms, matrix = 256 × 256, FOV = 24 ×
24 cm, slice thickness = 1.5 mm without gap).
The detailed processing protocol has been described in our
previous paper.39 Briefly, we calculated fractional anisotropy
values in the anterior cingulum using BioImage Suite
(www.bioimagesuite.org). For the cingulum delineation, we
reoriented DTI data into the coronal-oblique plane, resliced
to cubic voxel dimensions of 1 mm3 and smoothed by a 3-D
isotropic Gaussian kernel with sigma 1 mm. We then calcu-
lated the diffusion tensor matrices and fractional anisotropy
according to the methods of Basser and colleagues.28 The
absolute RGB (red-green-blue) colour-encoding scheme
defined the directionality of the principal eigenvector:40
left–right fibres in red, anterior–posterior fibres in green and
superior–inferior fibres in blue. The colour-coded diffusion
tensor imaging provided excellent distinction between the
cingulum and nearby bundles such as the corpus callosum
(Fig. 1a and b). An operator blind to diagnosis and genotype
delineated the cingulum bundle region of interest (ROI). The
ROI included voxels containing fibres travelling in the
anterior–posterior direction that also exhibited fractional
anisotropy higher than 0.2 to exclude grey matter (Fig. 1c).41
We defined the coronal-oblique slice passing through the
midpoint of the anterior commissure–posterior commissure
line as the reference slice after the 3D spoiled gradient re-
called acquisition scan was coregistered to the non–diffusion
weighted images. We calculated anterior cingulum fractional
anisotropy as the average of fractional anisotropy values over
5 slices (5-mm intervals between slices) anterior to the refer-
ence slice. The inter-rater reliabilities for manual delineation
of the cingulum were satisfactory with intraclass correlation
coefficients of 0.91–0.93.
DNA collection
We extracted DNA samples from white blood cells. We geno-
typed SNP8NRG221533 (rs35753505) by direct sequencing
from a polymerase chain reaction template. We applied the
automated DNA sequencer (ABI PRISM TM377) for sequen-
cing. Primers were as follows: upper 5′GCATTAGAACTA-
GAACTTGCGTGA3′ and lower 5′TGGGAACTCTC-
CATCTCTTTCA3′.
Statistical analysis
We performed all statistical analyses using SPSS for Win-
dows software, version 10.0 (SPSS Inc.). We performed in-
dependent Student t tests to assess potential differences in
demographic and clinical features between participant
groups. We investigated genotype frequencies with the
Fisher exact test to test for Hardy–Weinberg equilibrium.
According to the allele distributions in our large sample,16
we separated the control and schizophrenia groups into
2 subgroups, respectively: those homozygous for the more
frequent allele (C) and carriers of the less frequent allele (T)
who were heterozygous and homozygous for that allele. We
used a mixed-effects model analysis with diagnosis (control,
schizophrenia) and genotype (C/C, T carriers) as between-
subject variables and hemisphere (left, right) as the within-
subject variable. The mean fractional anisotropy measures
for the anterior cingulum for each participant were the
dependent variables. There was a random subject effect. We
tested all 2- and 3-way interactions between diagnosis, geno-
type and hemisphere. We calculated least square means and
standard errors (SEs) in the mixed model and plotted them
to interpret significant interactions. We set statistical signifi-
cance at p < 0.05. We additionally performed a second
mixed-effects model analysis analogous to the main statis-
tical model that included the CT and TT genotypes as
between-subject variables to explore the possibility of differ-
ences in effects between these 2 genotype subgroups.
Results
We included in our study 31 men with schizophrenia with a
mean age of 28.9 (standard deviation [SD] 5.5, range 19–
38) years. We also included 36 healthy men with a mean age
of 27.3 (SD 6.1, range 18–39) years in the control group.
The participants with schizophrenia were taking atypical
Fig. 1. Sagittal (a) and coronal (b) images from the tensor colour
map display the anterior–posterior coursing fibres of the cingulum
in green, left–right fibres in red and superior–inferior fibres in blue.
Coronal image (c) from the fractional anisotropy map displays the
voxels with fractional anisotropy values higher than 0.2. The red
and yellow circles in coronal images (b and c) demonstrate the
delineations for the right and left cingulum.
antipsychotic medications (risperidone, olanzapine or clozap-
ine). The healthy controls did not have histories of Axis I
mental disorders, nor did their first-degree relatives. No par-
ticipants had histories of major medical disorders, head
injuries (loss of consciousness longer than 5 min), neurologic
disorders or alcohol or substance abuse or dependence. 
Within the control group, 18 participants were homo-
zygous for the C allele (C/C) and 18 were T carriers (30%
T/T). Within the schizophrenia group, 15 had the C/C geno-
type and 16 were T carriers (25% T/T). Genotype distribu-
tions in the 2 groups did not differ significantly from each
other (p = 0.54) or from Hardy–Weinberg equilibrium
(p = 0.68 for the schizophrenia group and p = 0.14 for the con-
trol group). The groups did not differ significantly in age
(p = 0.75) or education (p = 0.10). Age at onset of schizophre-
nia and medication dose did not differ significantly between
patients with different genotypes (Table 1).
The main effect of diagnosis on anterior cingulum frac-
tional anisotropy values was significant: F1–63 = 7.07, p = 0.010.
Fractional anisotropy in the anterior cingulum was lower in
the schizophrenia group than in the control group, which is
consistent with the results of other studies by our group and
studies by other research groups.34–36 The diagnosis by geno-
type interaction was significant: F1–63 = 6.78, p = 0.012. Among
patients with schizophrenia, T carriers had significantly
lower fractional anisotropy than C/C homozygotes:
F1–29 = 5.27, p = 0.029. Within-genotype comparisons showed
that T carriers with schizophrenia had significantly decreased
fractional anisotropy values in the anterior cingulum com-
pared with healthy controls who were T carriers: F1–32 = 18.00,
p < 0.001 (Fig. 2). There were no other significant 2- or 3-way
interactions. In the secondary analysis exploring the potential
for different effects between the CT and TT genotypes there
was no significant effect of genotype (F1–30 = 0.065, p = 0.80) or
diagnosis by genotype interaction (F1–30 = 0.937, p = 0.34).
Discussion
Our results are consistent with those of the most recent stud-
ies suggesting that NRG1 contributes to the pathophysiol-
ogy of schizophrenia by exerting an effect on white matter.
For example, Winterer and colleagues12 found that variation
in the same NRG1 SNP examined in our study is associated
with medial frontal white matter integrity in healthy white
people. In that study, voxel-based DTI was used, and the
regions that differed significantly in fractional anisotropy
between the 2 genotype groups included the anterior cingu-
lum. Another group detected an association between white
matter density and integrity in the anterior limb of the inter-
nal capsule and NRG1 variant SNP243177 (rs6994992), an-
other SNP from the deCODE haplotype.13 That group also
reported that SNP243177 affected frontotemporal brain func-
tion and psychotic symptoms in individuals at high risk for
schizophrenia.42 Taken together, these findings suggest that
although the specific pathophysiological contributions of
NRG1 variation to alterations in anterior cingulum struc-
tural integrity in patients with schizophrenia cannot be con-
cluded from the present results, it seems feasible that
SNP8NRG221533 or related haplotypes may alter NRG1
expressions in the anterior cingulum, which then influence
myelin or oligodendrocyte development and possibly plas-
ticity in adulthood. Of note, it is possible that all these SNPs
might be markers of the deCODE haplotype and that the
disease locus might be in another part of the NRG1 gene.
We recently performed genetic association studies for the
SNPs (rs2919390, rs6988339 and rs3735774) located in the
region encoding the SMDF isoform, which is associated
with myelination.43 We identified an association between
rs3735774 (Arg46Gly) and schizophrenia in our case–
control and family-based association studies; however, the 
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Fig. 2. Fractional anisotropy values (least square means and stan-
dard errors of the means) in the anterior cingulum by diagnosis and
genotype. *T carriers with schizophrenia had significantly decreased
fractional anisotropy values in the anterior cingulum compared with
healthy T carriers and with the patients homozygous for CC.
Table 1: Characteristics of study participants, by genotype
Genotype; group; mean (SD)*
C/C C/T or T/T
Characteristic Controls (n = 18) Patients (n = 15) Controls (n = 18) Patients (n = 16)
Age, yr 28.56 (7.41) 27.27 (6.40) 26.06 (4.37) 28.25 (5.28)
Education, yr 14.17 (1.75) 12.87 (2.47) 13.89 (3.03) 13.18 (2.32)
Age at onset, yr NA 24.13 (7.47) NA 24.06 (4.61)
Dose of medication, mg† NA 326.67 (169.94) NA 339.06 (174.87)
FA values, least square mean (SE) 0.413 (0.021) 0.412 (0.023) 0.454 (0.017) 0.351 (0.018)
FA = fractional anisotropy; NA = not applicable; SD = standard deviation; SE = standard error.
*Unless otherwise indicated.
†Mean chlorpromazine equivalents.
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neuroimaging sample contained only 3 patients who were
C carriers and 4 healthy controls who were C carriers. Thus
there was not sufficient statistical power to investigate effects
on our DTI measures. This would be an SNP of interest to
explore in future studies. Our pilot results did not show the
association of SNPs (rs2919390 and rs6988339) with schizo-
phrenia (unpublished results).
Our study implicates an interaction between the diag-
nosis of schizophrenia and the NRG1 genetic variation
SNP8NRG221533 in influencing the structural integrity of
white matter in the anterior cingulum. Interestingly, Law
and colleagues44 observed a significant interaction between
the diagnosis of schizophrenia and another NRG1 genetic
variation (SNP8NRG221132) on type I mRNA in the hip-
pocampus. Although the 2 studies examined different SNPs
and different brain regions, taken together, they suggest
that NRG1 variation interacts with the diagnosis of schizo-
phrenia to influence the expression of corticolimbic pathol-
ogy in the disorder. These studies also raise the possibility
that different NRG1 variations may play different roles in
the pathophysiology of corticolimbic abnormalities in the
disorder.
Although these data provide preliminary indications of
how genetic variation in high-risk regions influences suscept-
ibility to corticolimbic abnormalities in patients with schizo-
phrenia, NRG1 is a complex gene,45,46 and many unanswered
questions about its specific effects in schizophrenia remain.
Neuregulin 1 is a large gene that may exert its effects by
many isoforms through alternative splicing. The specific vari-
ations that confer susceptibility to schizophrenia and that
might contribute to myelination abnormalities are not clear.
Postmortem histological studies of people with schizophre-
nia have revealed abnormalities in the expression patterns of
NRG1 mRNA isoforms in the dorsal prefrontal cortex47 and
the hippocampus.44 One postmortem study that specifically
investigated frontal SNP8NRG221533 expression did not
detect differences in these expression patterns in patients
with schizophrenia.47 However, the tissue investigated in that
study was derived from cortical grey matter. Thus this does
not necessarily contradict our current finding, which was
derived from a measurement in a white matter fibre bundle
where it would be more likely to observe myelination-related
differences. Confirmation of the role of SNP8NRG221533 in
studies of the cingulum is warranted.
Limitations
Our study had some limitations. One limitation was the use
of only fractional anisotropy as an index of myelin integrity.
In future studies, other DTI measurements (e.g., apparent dif-
fusion coefficient, relative anisotropy) may provide comple-
mentary information. In addition, we used DTI acquisition
methods to optimize study of the cingulum; however, this
limited our ability to study other brain regions that may also
be involved in schizophrenia.48,49 Further studies are war-
ranted to explore other brain regions and other possible
genetic risk regions. Finally, owing to the small sample size
of the TT subgroup, we did not perform the analyses on the
fractional anisotropy values in the anterior cingulum among
3 genotype groups. Therefore, it could not be concluded from
the current study whether the effect of the T allele is dom-
inant or codominant.
In summary, a genetic variation in NRG1 is associated
with more pronounced abnormalities in the structural in-
tegrity of the anterior cingulum in patients with schizophre-
nia. Further understanding of the contribution of variation in
NRG1 may help to elucidate the pathophysiological mechan-
isms underlying white matter abnormalities in corticolimbic
circuitry in the disorder.
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